Keloid Research Foundation
Established in 2011 by Dr. Michael H. Tirgan, the KRF is a 501 (C)(3), non for profit medical research and educational organization. The mission of KRF is to foster scientific research in keloid disorder and to promote education, advocacy, and service to those who suffer from this disorder. Donors can deduct contributions they make to KRF under IRC Section 170.
Language: English
We work every day to improve and protect the health of animals through scientific innovation, education and inspiration. We are committed to fighting animal diseases worldwide in dogs, cats, horses and wildlife.
We help millions of marketers discover how to best use social media marketing to connect with customers, generate awareness, and increase sales.
CIFOR is a non-profit, scientific institution that conducts research on forest and landscape management globally. CIFOR aims to improve human well-being, protect the environment, and increase equity.
The Dana Foundation is a private philanthropy that explores the connections between neuroscience and society's challenges and opportunities.
A research and educational institution whose mission is to build and promote conservative public policies, based in Washington, D.C.
Founded in 1982 by Michael and Lowell Milken, the Milken Family Foundation's core inspiration is to unlock the power of human potential through innovations in education. The mission-to empower people to help themselves and those around them live productive, satisfying lives-has directed our efforts for four decades and continues to be our guiding principle.
The Turkish Cultural Foundation was established on January 1, 2000. The Foundation is a US tax-exempt public charitable organization supported entirely by private donations, with offices in Boston, Washington DC and Istanbul.
The homepage of the Case Foundation, an organization that invests in people and ideas that can change the world.
The ASCAP Foundation
The Michael J. Fox Foundation is dedicated to finding a cure for Parkinson's disease through an aggressively funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's today.